Overview

Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)

Status:
Completed
Trial end date:
2005-01-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine while the pain is still mild.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Rizatriptan